|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.122 HKD | -12.86% |
|
-12.86% | -15.28% |
Wai Chun Bio-Technology Limited reported earnings results for the eighteen months ended June 30, 2022. For the period, the company reported sales was HKD 1,007.19 million. Net loss was HKD 23.53 million.
Basic loss per share from continuing operations was HKD 0.014. Diluted loss per share from continuing operations was HKD 0.014.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.28% | 3.07M | |
| -12.80% | 3.85B | |
| +12.49% | 1.84B | |
| +1.49% | 725M | |
| -20.88% | 425M | |
| -81.65% | 216M | |
| -18.93% | 104M | |
| -7.61% | 57.8M |
WAI CHUN BIO-TECHNOLOGY LIMITED 
